Addressing the Rural Opioid Crisis 2016 National Coalition of Black - - PowerPoint PPT Presentation

addressing the rural opioid crisis
SMART_READER_LITE
LIVE PREVIEW

Addressing the Rural Opioid Crisis 2016 National Coalition of Black - - PowerPoint PPT Presentation

Addressing the Rural Opioid Crisis 2016 National Coalition of Black Lung and Respiratory Disease Clinics Conference Lexington, Kentucky September 15, 2016 3:20-4:20 p.m. Presenters Nisha Patel, FORHP Holly Andrilla, WWAMI Rural


slide-1
SLIDE 1

Addressing the Rural Opioid Crisis

2016 National Coalition of Black Lung and Respiratory Disease Clinics Conference

Lexington, Kentucky September 15, 2016 3:20-4:20 p.m.

slide-2
SLIDE 2

Presenters

  • Nisha Patel, FORHP
  • Holly Andrilla, WWAMI Rural Health

Research Center

  • Shane Britt, Scottsville Allen County Faith

Coalition, Inc.

slide-3
SLIDE 3

Federal Response to the Opioid Crisis

Nisha Patel, MA, CHES Acting Associate Director/Senior Advisor Federal Office of Rural Health Policy

Black Lung Coalition Meeting September 15th, 2016

slide-4
SLIDE 4

Historical Data

4

  • Since 2002, the rate of drug overdose deaths has increased by

79%, with 200% increase involving opioids

  • In 2014, opioids were involved in 28,647 deaths
  • Only 2% of US physicians have obtained DEA DATA waivers to

prescribe buprenorphine

  • Only 16% of all psychiatrists have obtained waivers
  • Only 3% of all primary care physicians have obtained waivers
  • More than 30 million Americans live in counties without access to

buprenorphine treatment

  • 82% of the counties without a physician who could prescribe were in

rural areas

slide-5
SLIDE 5

Though opioid abuse and opioid-related death has been on the rise nationally, rural communities are disproportionately affected

Drug-related deaths 45% higher in rural Rural communities have a history of substance abuse

  • Rural has greater prevalence of risk factors

and fewer options for treatment.

Rural residents are most likely to be prescribed opioid painkillers

slide-6
SLIDE 6

Rural Trends

  • Opioid-related overdose deaths have

increased over the past 15 years in both rural and urban, with exponential increases in rural areas from 2013-2014

Trend 1

  • Rural states are more likely to have higher

rates of overdose death, particularly from prescription opiate overdose

Trend 2

  • Rural men may be using more, but rural

women are dying more

Trend 3

slide-7
SLIDE 7

Crude Heroin Overdose Mortality Rate (2014)

Heroin Overdose Mortality Rates and Rurality (2014)

>50% Rural <50% Rural Heroin Overdose Rate >2.9% in 2014 OH, WV, NH, NM, MO, IL, VT, MI, KY, WI, WA, PA, UT, AK, OR, ME CO, AZ CT, MA, RI, DE, DC, MD, NJ, NY, VA Heroin Overdose Rate <2.9% in 2014 NC, IN, AL, TN, LA, NV, MN, TX, GA, SC, IA, MS, OK FL, CA

slide-8
SLIDE 8

Crude Overdose Mortality Rate (2014)

Opioid Overdose Mortality Rates and Rurality (2014)

>50% Rural <50% Rural Overdose Mortality >8.4% in 2014 WV, NH, NM, OH, KY, UT, OK, ME, TN, NV, MO, WI, SC, MI, VT, AK, NC, CO, WA, RI, MD, MA, CT, DE, DC Overdose Mortality Rate <8.4% in 2014 IL, WY, PA, AZ, OR, GA, IN, KS, AL, MN, AR, LA, MT, IA, ID, SD, TX, HI, MS, ND, NE VA, NY, NJ, FL, CA

slide-9
SLIDE 9

HHS Opioid Initiative

  • Launched by Secretary

Burwell in March 2015

  • Three priority areas
  • Improve opioid prescribing
  • Increase use of naloxone

to reverse opioid overdose

  • Expand use of Medication-

Assisted Treatment (MAT) for opioid use disorders

slide-10
SLIDE 10

HHS Response

Secretary’s Opioid Initiative (announced March 2015)

NIH FDA CDC HRSA SAMHSA AHRQ ACF

  • 1. Expand Medication Assisted Treatment
  • 2. Expand Access to Naloxone
  • 3. Improve usability of Prescription Drug Monitoring Programs

CMS IHS ONC

slide-11
SLIDE 11

HRSA Related Efforts

11

  • 2016 Substance Abuse Service Expansion (BPHC)
  • In March 2016 HRSA expects to award 100 million to nearly 300 health center grantees for

the expansion of substance abuse services

  • Substance Abuse Warmline (BPHC)
  • Peer-to-peer telephone consultation, focusing on substance use evaluation and

management for primary care clinicians

  • Project ECHO Collaborative (BPHC)
  • 1-year project with 10 health centers around the topic of MAT for substance use
  • Secretary’s 50 State Convening Focused on Preventing Opioid Overdose (ORO)
  • Delegates from across the country convene to collaborate, take action on opioid epidemic
slide-12
SLIDE 12

HRSA Related Efforts

  • HRSA Funded Research
  • Example: The FORHP funded Maine Rural Health Research Center project

"Catastrophic Consequences: The Rise of Opioid Abuse in Rural Communities”

  • The Rural Opioid Overdose Reversal Grant Program (FORHP)
  • In September 2015, the FORHP awarded $1.8 million to support rural communities in

reducing morbidity and mortality related to opioid overdoses

  • Health Care for the Homeless Demonstration Project (HAB)
  • 5-year initiative that supports innovative practices to increase entry and retention into

HIV care, as well as support services for patients who are homeless or unstably housed and those who are living with mentally illness or substance use disorders

  • Behavioral Health Workforce Education and Training Program (BHW)
  • Supports the training of the behavioral workforce to ensure an adequate supply of

professional and paraprofessionals across the country, and in particular, within underserved and rural communities (FY2014)

12

slide-13
SLIDE 13

Rural Opioid Overdose Reversal Grant Program (ROOR)

  • New FY15 Pilot Program
  • Total investment: 18 awards at $100,000/year ($1.8 Million)
  • Support rural community partnerships comprised of local

emergency responders and other entities involved in the prevention and treatment of opioid overdoses

  • Increasing access to Naloxone in rural communities
  • Changing the mindset of law enforcement
slide-14
SLIDE 14

Program Goals:

  • Improve Access: Increase the availability of naloxone

through purchase and strategic placement;

  • Educate: Train licensed healthcare professionals and others

using the devices to recognize the signs of opioid overdose, administer naloxone, administer basic cardiopulmonary life support, report results, and provide appropriate transport to a hospital or clinic for continued care after administration;

  • Coordinate Care: Referral to substance abuse treatment

centers where care coordination can be provided by team of providers;

  • Improve Outcomes: Demonstrate improved and

measureable health outcomes, including reducing opioid

  • verdose morbidity and mortality in rural areas
slide-15
SLIDE 15

Map of ROOR Grantees

slide-16
SLIDE 16

100 200 300 400 500 600

Number of Trainings Number Trained

47 586

slide-17
SLIDE 17

370 1461 142 Narcan Devices Purchased

Nasal Narcan Injectable Evzio

slide-18
SLIDE 18

Opioid Crisis Meets Innovation

  • Diversion Alert, Maine
  • Serves Tribal communities
  • Created a patient education video for Native Americans

prescribed take home naloxone on how to respond to an

  • verdose.
  • Erie County Health Department, Ohio
  • Partnership includes mental health organizations
  • Training providers and family members to recognize overdose

signs

  • Distribute Evzio to first responders and loved ones of high-risk

drug users

  • “Circle of care,” ensuring substance use disorders are treated

like other health issues.

slide-19
SLIDE 19

Opioid Crisis Meets Innovation through Patient Navigation

Domestic AIDS Network, Maine

  • Shift focus of providers
  • Treat patients with dignity and respect
  • Focus on addressing the harms associated with the addiction
  • Integration of behavioral health into primary care
  • Harm Reduction Coalition
  • Training and technical assistance to providers
  • Utilization of peer navigators
  • Establish trust with patients
  • Connect patients to care
  • Schedule appointments
  • Make travel and childcare arrangements
slide-20
SLIDE 20

Other FORHP Resources

Reduce

  • pioid

misuse and

  • verdose

Telehealth Programs Rural Healthcare Outreach Program Rural Network Programs

slide-21
SLIDE 21

Integration Between Health and Human Services

Armstrong Indiana Clarion

  • Rural Health Care Services Grantee (2012 & 2015)
  • Program serves people with substance abuse addiction
  • Program has expanded to cover numerous counties
  • Coordinated Team Approach
  • Deliver high quality of care to patients
  • Build trust with the patient and recognize family
  • Hospital, local provider, nurse navigator, case manager
  • Hospital → Residential rehab → Outpatient care → Case

manager (transportation, daycare, medical assistance, housing, employment)

Heroin addict arrived at hospital with suicide thoughts. She was admitted to hospital psychiatric, discharged home with a planned admission date for inpatient drug treatment, stayed in touch with case manager, changed her living environment and believes “this program saved my life”.

slide-22
SLIDE 22

Collaboration is Key

Patients

Families

Law Enforcement Policymaker

Providers

slide-23
SLIDE 23

For Patients & Families

  • 1. SAMHSA Opioid Overdose Prevention Toolkit
  • http://store.samhsa.gov/product/Opioid-Overdose-Prevention-

Toolkit-Updated-2016/SMA16-4742

  • 2. Opioid Treatment Program Locator
  • http://dpt2.samhsa.gov/treatment/directory.aspx
  • 3. SAMHSA Opioid Overdose Toolkit: Safety Advice for

Patients & Families

  • http://store.samhsa.gov/shin/content/SMA13-

4742/Toolkit_Patients.pdf

  • 4. Community Health Gateway Toolkits
  • Rural Services Integration Toolkit:

https://www.ruralhealthinfo.org/community-health/services-integration

  • Rural Mental Health & Substance Abuse Toolkit:

https://www.ruralhealthinfo.org/community-health/mental-health

  • Coming Soon: Addiction Toolkit
slide-24
SLIDE 24

For Providers

  • 1. National Academy for State Health Policy
  • Rural primer on best practices around opioid abuse (Coming Soon)
  • Interviewed FORHP grantees and doing research around other models

proven to work

  • 2. CDC Opioid Prescribing Guidelines
  • http://www.cdc.gov/drugoverdose/prescribing/guideline.html
  • 3. SAMHSA MAT of Opioid Use Disorder Pocket Guide
  • http://store.samhsa.gov/product/Medication-Assisted-Treatment-of-Opioid-Use-Disorder-

Pocket-Guide/Most-Popular/SMA16-4892PG?sortByValue=4

  • 4. SAMHSA Clinical Guidelines for Use of Buprenorphine
  • http://store.samhsa.gov/product/TIP-40-Clinical-Guidelines-for-the-Use-of-Buprenorphine-in-

the-Treatment-of-Opioid-Addiction/SMA07-3939

slide-25
SLIDE 25

For Law Enforcement

  • HHS Website
  • http://www.hhs.gov/opioids/law-enforcement-

resources/index.html

  • Naloxone Toolkit
  • Collaboration between DOJ and IHS
  • https://www.bjatraining.org/tools/naloxone/Naloxo

ne-Background

slide-26
SLIDE 26

Primer for Medicaid-Safety Net Collaboration to Address Opioid Disorders

http://nashp.org/wp-content/uploads/2016/09/Rural-Opioid-Primer.pdf

http://nashp.org/wp-content/uploads/2016/09/Rural-Opioid- Infographic.pdf

slide-27
SLIDE 27

Keeping in Mind….

“After doing a presentation at a local church, a mother and son came and talked to me afterwards. The son told me that he had been battling heroin addiction for several years, but was

  • n Vivitrol, and said that it had been working wonders for him.

He than thanked me for training him to carry and use Naloxone, and told me that he had many friends that still used heroin, and was glad he now had an alternative to death that he could carry in his pocket in case one of his friends

  • verdosed. This is because of this grant.”

San Luis Valley AHEC, Colorado

slide-28
SLIDE 28

CHALLENGES IN THE PROVISION OF TREATMENT FOR OPIOID USE DISORDER IN RURAL PLACES

  • C. Holly A. Andrilla, MS

Cynthia Coulthard, MS Eric H. Larson, PhD

slide-29
SLIDE 29

Disclaimer

This work was supported by the Federal Office of Rural Health Policy (FORHP), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS) under cooperative agreement #U1CRH03712. The information, conclusions and opinions expressed in this presentation are those of the authors and no endorsement by FORHP, HRSA, or HHS is intended

  • r should be inferred.
slide-30
SLIDE 30

Background

Opioid Use Rates and Overdose Deaths

  • In 2013, over 5 million Americans abused or were dependent on opioids
  • Prescription pain relievers: 4.5 million, Heroin: estimated 681,000 past year

users

  • From 2001 to 2013 there was a 3-fold increase in the total

number of deaths.

slide-31
SLIDE 31

Challenges in the Provision of Opioid use disorder treatment in rural areas

  • 1. Lack of treatment facilities
  • 2. Lack of trained providers and “back-up providers” in

places where there are providers

  • 3. Lack of mental health specialists to treat comorbidities
  • 4. Lack of anonymity in small communities
  • 5. Lower socio economic status of many rural residents and

communities which leads to travel difficulty for services and lack of support services for people in recovery

slide-32
SLIDE 32

Medication Assisted Treatment (MAT)

Buprenorphine-naloxone is an effective treatment for

  • pioid use disorder that can be provided in an office-

based setting

  • To expand treatment options the US Congress passed the Drug Addiction

Treatment Act (DATA 2000)

  • Allows providers who complete training to prescribe buprenorphine to

treat opioid use disorder

  • Legislation has been recently passed to lift the cap on the number of

patients a physician can treat and to expand the option to get a waiver to nurse practitioners and physician assistants (both can prescribe

  • piates in states where scope of practice allows it).
slide-33
SLIDE 33
slide-34
SLIDE 34
slide-35
SLIDE 35

State Total Counties Counties with at least 1 waivered provider Vulnerable Counties -Have a single waivered provider N (%*) Counties without any waivered providers N (%)

Kentucky

120 73 22 (30%) 47 (39%)

Tennessee

95 64 20 (31%) 31 (33%)

West Virginia

55 30 3 (10%) 25 (45%)

Virginia

95 68 16 (24%) 27 (28%)

Illinois

102 44 17 (32%) 58 (57%)

Indiana

92 50 12 (24%) 42 (46%)

Ohio

88 68 13 (19%) 20 (23%)

Pennsylvania

67 61 6 (10%) 6 (9%)

*of counties with at least one waivered provider Data Source: DEA Waivered Physician List, April 2016

slide-36
SLIDE 36
slide-37
SLIDE 37

State Total Counties Counties with at least 1 waivered provider Vulnerable Counties - Have only a single waivered provider N (%*) Counties without any waivered providers N (%)

Nevada

17 11 5 (45%) 6 (35%)

Utah

29 16 4 (25%) 13 (45%)

Colorado

64 27 12 (44%) 37 (58%)

Arizona

15 13 2 (15%) 2 (13%)

New Mexico

33 20 3 (15%) 13 (39%)

*of counties with at least one waivered provider Data Source: DEA Waivered Physician List, April 2016

slide-38
SLIDE 38

Supply of Physicians with DEA DATA Waivers in US Counties, by Rural-Urban Status

Characteristic Metropolitana Adjacent to Metropolitanb Micropolitan, Not Adjacent to Metropolitanc Small and Remote Rural Countiesd Total UIC 1-2 UIC 3-7 UIC 8 UIC 9-12 US Population, No. (%) 260,479,400 (83.6) 33,691,096 (10.8) 9,677,339 (3.1) 7,744,082 (2.4) 311,591,917 (100.0) Counties with ≥1 physicians with waivers,

  • No. (%)

789 (72.4) 419 (39.6) 132 (46.8 125 (17.5) 1,465 (46.6) Counties with no physician with a waiver,

  • No. (%)

301 (27.6) 639 (60.4) 150 (53.2) 588 (82.5) 1,678 (53.4) Total counties, No. (%) 1,090 (34.7) 1,058 (33.7) 282 (9.0) 713 (22.7) 3,143 (100.0) Physicians with waivers per 100,000 residents, No. 6.3 3.3 4.2 3.1 5.8 Physicians with waivers, % 90.4 6.1 2.3 1.3 100.0

DATA = Drug Addiction Treatment Act; DEA = Drug Enforcement Administration; UIC = Urban Influence Code. Note: counties were classified as urban or into 1 of 3 categories of rural using the US Department of Agriculture UIC.

a Counties with an urban core with a population of at least 50,000. b Counties that are geographically adjacent to a metropolitan area whose largest town/urban cluster has 10,000-49,999 residents. c Counties that are not adjacent to a metropolitan area and whose largest town/urban cluster has 10,000-49,999 residents. d Counties whose largest town has fewer than 10,000 residents regardless of proximity to a micropolitan county.

slide-39
SLIDE 39

Lack of trained providers and “back-up providers” in places where there are providers

US Counties with at least 1 DEA DATA Waivered Physician in US Counties, by Rural-Urban Status

Metropolitana Adjacent to Metropolitanb Micropolitan, Not Adjacent to Metropolitanc Small and Remote Rural Countiesd Total

Single Physician w/DEA waivere 14.5% 43.8% 44.1% 63.1% 29.9%

DATA = Drug Addiction Treatment Act; DEA = Drug Enforcement Administration; UIC = Urban Influence Code. Note: counties were classified as urban or into 1 of 3 categories of rural using the US Department of Agriculture UIC.

a Counties with an urban core with a population of at least 50,000. b Counties that are geographically adjacent to a metropolitan area whose largest town/urban cluster has 10,000-49,999 residents. c Counties that are not adjacent to a metropolitan area and whose largest town/urban cluster has 10,000-49,999 residents. d Counties whose largest town has fewer than 10,000 residents regardless of proximity to a micropolitan county. e Based on the July 2012 DEA Waivered Physician list

slide-40
SLIDE 40

Lack of mental health specialists to treat comorbidities

Mental Health Providers in US Counties, by Rural-Urban Status

Metropolitana Adjacent to Metropolitanb Micropolitan, Not Adjacent to Metropolitanc Small and Remote Rural Countiesd Total

Counties Lacking a Psychiatriste 27% 59% 39% 86% 51% Psychiatrists per 10,000 populatione 1.8 0.5 0.9 0.4 1.6

Note: counties were classified as urban or into 1 of 3 categories of rural using the US Department of Agriculture Urban Influence Codes.

a Counties with an urban core with a population of at least 50,000. b Counties that are geographically adjacent to a metropolitan area whose largest town/urban cluster has 10,000-49,999 residents. c Counties that are not adjacent to a metropolitan area and whose largest town/urban cluster has 10,000-49,999 residents. d Counties whose largest town has fewer than 10,000 residents regardless of proximity to a micropolitan county. e Based on the National Plan and Provider Enumeration System

slide-41
SLIDE 41

Lower socio economic status of many rural residents and communities

Persistent Poverty Status and Median Household Income in US Counties, by Rural-Urban Status

Metropolitana Adjacent to Metropolitanb Micropolitan, Not Adjacent to Metropolitanc Small and Remote Rural Countiesd Total

Persistent Povertyf Countiese 4.5% 14.0% 14.1% 17.5% 11.2% Average County Median Household Incomee $52,204 $41,827 $44,201 $42,415

Note: counties were classified as urban or into 1 of 3 categories of rural using the US Department of Agriculture Urban Influence Codes.

a Counties with an urban core with a population of at least 50,000. b Counties that are geographically adjacent to a metropolitan area whose largest town/urban cluster has 10,000-49,999 residents. c Counties that are not adjacent to a metropolitan area and whose largest town/urban cluster has 10,000-49,999 residents. d Counties whose largest town has fewer than 10,000 residents regardless of proximity to a micropolitan county. e Based on the Health Area Resource File 2014-15 Release f 20 percent or more of the county population has lived in poverty over the past 30 years

slide-42
SLIDE 42

Challenges in getting Opioid use disorder treatment in rural areas

  • Essentially no Opioid Treatment Centers in rural places
  • Virtually no specialists in rural areas- Note psychiatrists

held 42% of all waivers in 2012

  • Long Travel Distances to Opioid Treatment Center have

costs both in terms of time and money.

  • Social stigma impacts treatment in places where people

are more easily identified

  • Buprenorphine can be prescribed by a primary care

provider (with a waiver)

  • Buprenorphine can be prescribed in an office-base

setting

slide-43
SLIDE 43

Current Study by WWAMI RHRC

Survey of all waivered providers (April 2016) located in a rural place (approximately 2500)

  • Are they currently using their waiver (and have they ever)?
  • How many patients are they currently treating?
  • What patients will they accept for treatment? (their own, clinic,

community, others)

  • Do they practice with other waivered physicians
  • Barriers to incorporating Buprenorphine into their practice
  • Demographics
slide-44
SLIDE 44

Early Results

Most Frequently Cited Barriers to Incorporating Buprenorphine into their practice

  • 1. Concerns about diversion or misuse of medication (50%)
  • 2. Lack of available mental health or psychosocial support services

(45%)

  • 3. Time constraints (42%)

About 1/3 of responding physicians indicated the following were barriers to incorporating Buprenorphine into their practice Financial/reimbursement concerns, Lack of specialty backup for complex problems, and Attraction of drug users to your practice

slide-45
SLIDE 45

The Rural Health Research Gateway provides access to all publications and projects from eight different research centers. Visit our website for more information.

ruralhealthresearch.org

Sign up for our email alerts! ruralhealthresearch.org/alerts

Center for Rural Health University of North Dakota 501 N. Columbia Road Stop 9037 Grand Forks, ND 58202

slide-46
SLIDE 46
  • C. Holly A. Andrilla

hollya@uw.edu 206-685-6680 4311 11th Ave NE Suite 210 Seattle, Wa 98105

slide-47
SLIDE 47
slide-48
SLIDE 48
slide-49
SLIDE 49

GRANT FUNDED THROUGH U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES—HEALTH RESOURCES AND SERVICES ADMINISTRATION

Opioid Overdose Reversal Grant Program

slide-50
SLIDE 50
slide-51
SLIDE 51
slide-52
SLIDE 52
slide-53
SLIDE 53
slide-54
SLIDE 54

QUESTIONS?

Thank you to our presenters!